Carlos Frade, Vice President of R&D Solutions, will be presenting, and participating as a session panelist at the Conference for Management and Use of Electronic Systems in Pre-Clinical Studies in Beijing on 5 June 2012. The conference, being held on behalf of SFDA by China Center for Pharmaceutical International Exchange and includes speakers and participants from the U.S. FDA and the China SFDA.
Foamix Ltd., a clinical-stage specialty pharmaceutical company, that is developing proprietary dermatological and gynecologic topical foam products, announced today that the Company has obtained another granted patent in Mexico.
Now it's in 5th year, Pipe Tech World Summit will be taking place on the 13th - 15th June 2012 at the Grand Cevahir Hotel & Convention Centre, Istanbul, Turkey.
The Early Drug Development Summit will be taking place on 3rd - 4th December 2012 in Berlin, Germany. The summit is the must attend event for all those looking to successfully shorten lengthy and arduous drug development timelines whilst bringing, safe and efficacious drugs to market faster.
High purity tubing manufacturer AdvantaPure will exhibit its single use products and molded components for the pharmaceutical and bioprocess industries at two upcoming events, Interphex and the Single Use Applications Conference. The company will highlight its single use tubing of silicone and TPE and its molded fitting connections.
Foamix Ltd., a clinical-stage specialty pharmaceutical company, that is developing proprietary dermatological and gynecologic topical foam products, today announced that the company has been granted a new patent from United States Patent Office.
Xybion Corporation announced that its Pristima Preclinical Software suite has been selected as the primary preclinical platform for early-stage drug discovery pathology data management by a Top-5 global biotech firm.
Mikel Moyer, Vice President of Molecular Discovery at Epizyme will give a presentation on "Protein Methyl Transferases: a Novel Target Class for Molecularly Targeted Therapy against Genetically Defined Cancers" at the 2nd Epigenetics in Drug Discovery Conference taking place on May 30-31, 2012 in Boston, MA.
Mark Labow, Executive Director, Discovery Unit: Developmental and Molecular Pathways Department, Novartis Institutes for BioMedical Research (NIBR) to give featured presentation entitled "Systematic, Genome-Scale Identification of Novel Drug Targets" at 2nd Genomic & Proteomic Drug Discovery Conference on May 30-31st in Boston, MA.
The Department of Developmental and Molecular Pathways has focus.
Maximizing Strategic Partnerships through Licensing and Merger & Acquisition Activity in the Pharmaceutical and Biotech Spaces by Exploring Creative Deal Structures, Overcoming Funding Restraints and Capitalizing on Key National and Global External Opportunities.
Xybion's Harry Huss to present and lead roundtable discussions at this year's SQA Annual meeting. Xybion will also be showcasing their unique integrated preclinical and quality/compliance solutions.
Vasco Marcal Grilo, Vice-President Global Pharma R&D Sourcing, Johnson & Johnson, will be sharing insights around the topic of 'Clinical Outsourcing in Emerging Markets' during a case study presentation at the Pharma Outsourcing and Procurement Summit, 21st - 22nd May 2012 in Hotel Palace Berlin, Germany.
Alexander Meissner, Assistant Professor at Harvard University will give a keynote presentation on "DNA Methylation Dynamics in Development and Stem Cells" at the 2nd Epigenetics in Drug Discovery Conference taking place on May 30-31, 2012 in Boston, MA.
Francesca Milleti, Head of Cheminformatics & Statistics at Hoffmann-La Roche to give a Featured Presentation on "SAR analysis 3.0" at the 6th Drug Design & Medicinal Chemistry Conference on June 7-8, 2012 in San Diego, CA
World Trade Group have successfully been organising and hosting events in the HR industry for over ten years. Following extensive market research, it became apparent that there was no outlet in the market that successfully sought to reward senior industry professionals who were actively contributing to developing and driving best practice strategies.
Foamix, a clinical stage specialty pharmaceutical company, announced today the successful completion of the Phase II clinical trial of Minocycline foam in Impetigo patients. Minocycline Foam has shown to be highly effective against bacteria, including some multi-drug resistant strains (such as MRSA).
Pharma executives from across Europe have attended the PharmiWeb Solutions Digital Breakfast to hear from cross-industry experts on how to navigate digital marketing successfully.
Satisfied Users & 
Approved Press Releases
